Pre-corticosteroid delusional psychosis and olanzapine-responsive behavioral dyscontrol in autoimmune glial fibrillary acidic protein astrocytopathy: A case report.

Publication date: Sep 01, 2026

Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is an immunotherapy-responsive inflammatory central nervous system disorder. Psychiatric manifestations include delirium, cognitive or behavioral change, apathy, depressive symptoms, and anxiety; however, frank delusional psychosis before corticosteroid exposure is rarely characterized. Timing is critical because corticosteroids can themselves cause psychosis. A 42-year-old man with no previous psychotic disorder developed a progressive subacute syndrome over several months, beginning with headache and followed by impaired fine motor function, dysarthria, dysphagia, tremor, and cognitive decline. Cerebrospinal fluid (CSF) showed inflammation, and CSF GFAP-immunoglobulin G (IgG) was confirmed by qualitative cell-based and tissue-based assays. Before corticosteroid pulse therapy or oral prednisolone, his family observed a new persecutory delusion that someone was outside the window. Immunotherapy was led by neurologists, and psychiatric symptoms were assessed by psychiatrists through consultation and later psychiatric hospitalization. After corticosteroid therapy, neurological symptoms partially improved, but persecutory ideas, grandiosity, insomnia, irritability, aggression, and escape behavior became prominent. Prednisolone was continued because of the autoimmune neurological disease. Olanzapine was titrated to 15 mg/day. Behavioral dyscontrol improved markedly despite continued prednisolone, and physical restraint was no longer required; however, residual grandiose delusional ideas persisted. This case suggests that delusional psychosis can be an early manifestation of autoimmune GFAP astrocytopathy. Because the first delusion preceded corticosteroid exposure, steroid-induced psychosis was excluded as the mechanism of onset. Olanzapine may stabilize severe behavioral dyscontrol while necessary corticosteroid therapy is maintained, although residual delusions may persist.

Concepts Keywords
15mg autoimmune encephalitis
Astrocytopathy delusion
Depressive GFAP astrocytopathy
Immunotherapy olanzapine
Old organic psychosis

Semantics

Type Source Name
disease MESH psychosis
drug DRUGBANK Olanzapine
disease MESH central nervous system disorder
disease MESH delirium
disease MESH anxiety
disease MESH syndrome
disease MESH headache
disease MESH dysarthria
disease MESH dysphagia
disease MESH tremor
disease MESH cognitive decline
disease MESH inflammation
drug DRUGBANK Prednisolone
disease MESH insomnia
disease MESH autoimmune encephalitis

Original Article

(Visited 36 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *